hotspot -WSS

hotspot

author：explore 2025-09-27 16:16:44 - browse：91

President Biden speaks on the Cancer Moonshot initiative at the John F. Kennedy Library in 2022. Evan Vucci/AP

WASHINGTON — The next chapter of President Biden’s moonshot to end cancer has landed. While the new goals are inspiring hope among cancer researchers, not everyone is impressed.

The president early Wednesday morning unveiled a slew of federal plans and private-sector agreements to fuel the relaunched Cancer Moonshot, a project to improve treatments and halve cancer deaths in the next 25 years. Among roughly 50 new programs and partnerships are multimillion-dollar pledges to advance testing, data pools, clinical trials and outreach efforts.

It is the latest phase of a project Biden first launched as vice president in the wake of his son Beau’s death from brain cancer in 2015. But while the first moonshot funneled money almost entirely to early-stage cancer research, its sequel is broadening efforts to prevent cancer deaths — particularly through anti-smoking efforts — and introduces a new focus on research infrastructure and patient engagement that some cancer researchers have applauded.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Researchers tackle phage therapy hurdles for wider adoption

hotspot

WSS

A public health expert passes on football's full body collisions for youths

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Altering the blood type of lungs raises potential for universal organs for transplants

A public health expert passes on football's full body collisions for youths

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

focus

hotspot

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

FDA warns medical device makers about rise in fabricated data

Drug repurposing or repositioning? The language matters

MD Anderson's Padmanee Sharma responds to research credit suit

Psychedelics group wrestles with new pharma identity

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Peter Hotez and the public health issue of online harassment

WATCH: Why do our ears pop?

Walensky prepares to leave CDC — and Congress — behind

Medicare Advantage enrollment grows 7.1% to 33.4 million people

focus

Biden administration plans revamp of organ transplant system

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Living organ donors deserve priority status for transplants

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Abridge raises $150m as clinical notes automation market heats up

As AI regulations shape up, health tech startups beg for clarity

hotspot

hotspot

entertainment

focus